Loading fund…
Loading fund…
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | ▼ −0.7% | ▲ +6.4% | ▲ +28.5% | ▲ +11.3% | ▲ +5.5% | — | — | ▲ +9.3% |
| Peer average | ▲ +0.0% | ▲ +0.4% | ▲ +0.9% | ▲ +10.9% | ▲ +12.8% | ▲ +69.6% | ▲ +56.2% | — |
| S&P 500 · VOO | ▼ −0.4% | ▲ +0.9% | ▲ +3.3% | ▲ +13.8% | ▲ +13.3% | ▲ +88.8% | ▲ +81.9% | — |
Typically, the Langar Global HealthTech ETF allocates at least 80% of its total assets, including any capital acquired through borrowing for investment, to equity securities. These holdings primarily consist of stocks and American Depository Receipts (ADRs) issued by healthcare technology companies, which are traded on exchanges both in the United States and internationally. The market capitalization of these companies is not a limiting factor for investment. This ETF operates as a non-diversified fund.
Distribution yield and SEC yield use different methodologies. Payouts may include income, capital gains, or return of capital.
Verified payout history is unavailable.
Estimated annual expense excludes trading costs and assumes constant assets. Fee waivers and fund costs can change.
Historical risk measures describe past behavior and do not predict future returns.
Hear the strategy from the people behind LGHT.